A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
PHASE1CompletedINTERVENTIONAL
Enrollment
38
Participants
Timeline
Start Date
Not specified
Study Completion Date
May 31, 1993
Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG
Ganciclovir
Trial Locations (2)
33136
Univ. of Miami AIDS CRS, Miami
Unknown
Washington U CRS, St Louis
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000673 - A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy | Biotech Hunter | Biotech Hunter